DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Mobic (Meloxicam) - Summary

 

-- advertisement --

WARNING

Cardiovascular Risk

  • NSAIDs may cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. This risk may increase with duration of use. Patients with cardiovascular disease or risk factors for cardiovascular disease may be at greater risk (see WARNINGS and CLINICAL TRIALS).

  • MOBIC tablets/oral suspension is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery (see WARNINGS).

Gastrointestinal Risk

  • NSAIDs cause an increased risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients are at greater risk for serious gastrointestinal events (see WARNINGS).
 

MOBIC SUMMARY

Mobic®
(meloxicam)
Tablets 7.5 mg and 15 mg
and
Mobic®
(meloxicam)
Oral Suspension 7.5 mg/5 mL

MOBIC® (meloxicam), an oxicam derivative, is a member of the enolic acid group of nonsteroidal anti-inflammatory drugs (NSAIDs). Each pastel yellow tablet contains meloxicam 7.5 mg or 15 mg for oral administration.

MOBIC is indicated for relief of the signs and symptoms of osteoarthritis.

MOBIC NEWS HIGHLIGHTS

Media Articles Related to Mobic (Meloxicam)

August 2004
Source: Medscape Primary Care Headlines [2004.08.18]

more>>

Published Studies Related to Mobic (Meloxicam)

The effects of a COX-2 inhibitor meloxicam on squamous cell carcinoma of the esophagus in vivo. [2008.04.01]

Effect of short-term treatment with meloxicam and pimobendan on the renal function in healthy beagle dogs. [2008.04]

Effects of carprofen and meloxicam with or without butorphanol on the minimum alveolar concentration of sevoflurane in dogs. [2008.01]

Evaluation of adverse effects of long-term oral administration of carprofen, etodolac, flunixin meglumine, ketoprofen, and meloxicam in dogs. [2007.03]

Safety of meloxicam in aspirin-hypersensitive patients with asthma and/or nasal polyps. A challenge-proven study. [2007]

more>>

Clinical Trials Related to Mobic (Meloxicam)

Food Study of Meloxicam Tablets 15 mg and Mobic® Tablets 15 mg [Completed]

Fasting Study of Meloxicam Tablets 15 mg and Mobic® Tablets 15 mg [Completed]

A Study to Compare Meloxicam IM Once Daily vs. Meloxicam Orally Once Daily in Patients With Rheumatoid Arthritis [Completed]

A Study to Compare Meloxicam IM Once Daily and Meloxicam Administered Orally Once Daily in Patients With Osteoarthritis [Completed]

A Study of Meloxicam [Mobic] in Juvenile Rheumatoid Arthritis (JRA) [Completed]

more>>

Page last updated: 2008-03-26

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008